Literature DB >> 22306201

RNA modifications by oxidation: a novel disease mechanism?

Henrik E Poulsen1, Elisabeth Specht, Kasper Broedbaek, Trine Henriksen, Christina Ellervik, Thomas Mandrup-Poulsen, Morten Tonnesen, Peter E Nielsen, Henrik U Andersen, Allan Weimann.   

Abstract

The past decade has provided exciting insights into a novel class of central (small) RNA molecules intimately involved in gene regulation. Only a small percentage of our DNA is translated into proteins by mRNA, yet 80% or more of the DNA is transcribed into RNA, and this RNA has been found to encompass various classes of novel regulatory RNAs, including, e.g., microRNAs. It is well known that DNA is constantly oxidized and repaired by complex genome maintenance mechanisms. Analogously, RNA also undergoes significant oxidation, and there are now convincing data suggesting that oxidation, and the consequent loss of integrity of RNA, is a mechanism for disease development. Oxidized RNA is found in a large variety of diseases, and interest has been especially devoted to degenerative brain diseases such as Alzheimer disease, in which up to 50-70% of specific mRNA molecules are reported oxidized, whereas other RNA molecules show virtually no oxidation. The iron-storage disease hemochromatosis exhibits the most prominent general increase in RNA oxidation ever observed. Oxidation of RNA primarily leads to strand breaks and to oxidative base modifications. Oxidized mRNA is recognized by the ribosomes, but the oxidation results in ribosomal stalling and dysfunction, followed by decreased levels of functional protein as well as the production of truncated proteins that do not undergo proper folding and may result in protein aggregation within the cell. Ribosomal dysfunction may also signal apoptosis by p53-independent pathways. There are very few reports on interventions that reduce RNA oxidation, one interesting observation being a reduction in RNA oxidation by ingestion of raw olive oil. High urinary excretion of 8-oxo-guanosine, a biomarker for RNA oxidation, is highly predictive of death in newly diagnosed type 2 diabetics; this demonstrates the clinical relevance of RNA oxidation. Taken collectively the available data suggest that RNA oxidation is a contributing factor in several diseases such as diabetes, hemochromatosis, heart failure, and β-cell destruction. The mechanism involves free iron and hydrogen peroxide from mitochondrial dysfunction that together lead to RNA oxidation that in turn gives rise to truncated proteins that may cause aggregation. Thus RNA oxidation may well be an important novel contributing mechanism for several diseases.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22306201     DOI: 10.1016/j.freeradbiomed.2012.01.009

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  64 in total

Review 1.  Clinical Relevance of Biomarkers of Oxidative Stress.

Authors:  Jeroen Frijhoff; Paul G Winyard; Neven Zarkovic; Sean S Davies; Roland Stocker; David Cheng; Annie R Knight; Emma Louise Taylor; Jeannette Oettrich; Tatjana Ruskovska; Ana Cipak Gasparovic; Antonio Cuadrado; Daniela Weber; Henrik Enghusen Poulsen; Tilman Grune; Harald H H W Schmidt; Pietro Ghezzi
Journal:  Antioxid Redox Signal       Date:  2015-10-26       Impact factor: 8.401

2.  Urinary DNA adductomics - A novel approach for exposomics.

Authors:  Marcus S Cooke; Chiung-Wen Hu; Yuan-Jhe Chang; Mu-Rong Chao
Journal:  Environ Int       Date:  2018-11-02       Impact factor: 9.621

3.  An efficient method for long-term room temperature storage of RNA.

Authors:  Anne-Lise Fabre; Marthe Colotte; Aurélie Luis; Sophie Tuffet; Jacques Bonnet
Journal:  Eur J Hum Genet       Date:  2013-07-17       Impact factor: 4.246

4.  Clarithromycin, trimethoprim, and penicillin and oxidative nucleic acid modifications in humans: randomised, controlled trials.

Authors:  Emil List Larsen; Vanja Cejvanovic; Laura Kofoed Kjaer; Morten Thorup Pedersen; Sara Daugaard Popik; Lina Kallehave Hansen; Jon Traerup Andersen; Espen Jimenez-Solem; Kasper Broedbaek; Morten Petersen; Allan Weimann; Trine Henriksen; Jens Lykkesfeldt; Christian Torp-Pedersen; Henrik Enghusen Poulsen
Journal:  Br J Clin Pharmacol       Date:  2017-03-17       Impact factor: 4.335

5.  Biophysical properties, thermal stability and functional impact of 8-oxo-7,8-dihydroguanine on oligonucleotides of RNA-a study of duplex, hairpins and the aptamer for preQ1 as models.

Authors:  Yu J Choi; Krzysztof S Gibala; Tewoderos Ayele; Katherine V Deventer; Marino J E Resendiz
Journal:  Nucleic Acids Res       Date:  2017-02-28       Impact factor: 16.971

6.  Reverse Transcription Past Products of Guanine Oxidation in RNA Leads to Insertion of A and C opposite 8-Oxo-7,8-dihydroguanine and A and G opposite 5-Guanidinohydantoin and Spiroiminodihydantoin Diastereomers.

Authors:  Anton Alenko; Aaron M Fleming; Cynthia J Burrows
Journal:  Biochemistry       Date:  2017-09-11       Impact factor: 3.162

Review 7.  Formation and processing of DNA damage substrates for the hNEIL enzymes.

Authors:  Aaron M Fleming; Cynthia J Burrows
Journal:  Free Radic Biol Med       Date:  2016-11-20       Impact factor: 7.376

8.  Systemic oxidative stress to nucleic acids is unaltered following radioiodine therapy of patients with benign nodular goiter.

Authors:  Steen J Bonnema; Elisabeth S Stovgaard; Søren Fast; Kasper Broedbaek; Jon T Andersen; Allan Weimann; Peter Grupe; Laszlo Hegedüs; Henrik E Poulsen
Journal:  Eur Thyroid J       Date:  2015-02-11

9.  Good stress, bad stress and oxidative stress: insights from anticipatory cortisol reactivity.

Authors:  Kirstin Aschbacher; Aoife O'Donovan; Owen M Wolkowitz; Firdaus S Dhabhar; Yali Su; Elissa Epel
Journal:  Psychoneuroendocrinology       Date:  2013-03-13       Impact factor: 4.905

10.  MicroRNAs: New players in cancer prevention targeting Nrf2, oxidative stress and inflammatory pathways.

Authors:  Chengyue Zhang; Limin Shu; Ah-Ng Tony Kong
Journal:  Curr Pharmacol Rep       Date:  2015-01-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.